INDV (Indivior Pharmaceuticals, Inc. Common Stock) Stock Analysis - Analyst Ratings
Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of May 20, 2026, INDV trades at $37.73 with a market cap of $4.32B and a P/E ratio of 22.16. INDV moved +2.42% today. Year to date, INDV is +3.53%; over the trailing twelve months it is +216.69%. Its 52-week range spans $7.33 to $41.00. Analyst consensus is strong buy with an average price target of $50.67. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What do analysts rate INDV?
4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $50.67.